Review



ccl4 levels  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems ccl4 levels
    Ccl4 Levels, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 22 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ccl4 levels/product/R&D Systems
    Average 93 stars, based on 22 article reviews
    ccl4 levels - by Bioz Stars, 2026-03
    93/100 stars

    Images



    Similar Products

    93
    R&D Systems ccl4 levels
    Ccl4 Levels, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ccl4 levels/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    ccl4 levels - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    90
    Meso Scale Diagnostics LLC mip-1β/ccl4 levels measured by meso scale
    Mip 1β/Ccl4 Levels Measured By Meso Scale, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mip-1β/ccl4 levels measured by meso scale/product/Meso Scale Diagnostics LLC
    Average 90 stars, based on 1 article reviews
    mip-1β/ccl4 levels measured by meso scale - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Meso Scale Diagnostics LLC plasma ccl3 and ccl4 levels
    Ibrutinib has similar effects on mitochondrial respiration profiles, CCL3 and 4, β-2 M, lactate dehydrogenase (LDH), Bruton tyrosine kinase (BTK) signaling and caspase-3 cleavage in chronic lymphocytic leukemia (CLL) patients independent of dose. The effect of ibrutinib treatment on basal respiration ( A ), maximal respiration ( B ), spare respiratory capacity ( C ), and respiratory control ratio ( D ) in primary CLL cells from patients pre-treatment and on ibrutinib treatment with low (blue) or standard (grey) dose. N = 14 for low dose and N = 5 for standard dose of ibrutinib. Values are mean ± S.D. **** p < 0.0001 (paired two-tailed Student’s t -test). The reduction of mitochondrial respiration parameters with low and standard dose of ibrutinib treatment is summarized for basal respiration ( E ) and maximal respiration ( F ) in freshly isolated CLL cells. N = 14 for low dose and N = 5 for standard dose of ibrutinib. Values are mean ± S.D. *** p < 0.0005, NS: non-significant (unpaired two-tailed Student’s t -test). In parallel, there is a reduction of chemokine ligands CCL3 ( G ) and <t>CCL4</t> ( H ) in ibrutinib treated CLL patient plasma samples by dose. Decreased levels of β-2 M and LDH in ibrutinib treated patients compared to pre-treatment ( I , K ) and the decrease of β-2 M or LDH was similar to low or standard dose ibrutinib CLL patients ( J , L ). Demonstration of effects on pBTK, tBTK ( M ), and caspase-3 cleavage ( N ) are independent of dose. OCR: Oxygen consumption rate; resp: Respiratory; IB: Ibrutinib; TX: Treatment; Uncl. caspase-3: Uncleaved caspase-3; Cl. caspase-3: Cleaved caspase-3.
    Plasma Ccl3 And Ccl4 Levels, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/plasma ccl3 and ccl4 levels/product/Meso Scale Diagnostics LLC
    Average 90 stars, based on 1 article reviews
    plasma ccl3 and ccl4 levels - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    Ibrutinib has similar effects on mitochondrial respiration profiles, CCL3 and 4, β-2 M, lactate dehydrogenase (LDH), Bruton tyrosine kinase (BTK) signaling and caspase-3 cleavage in chronic lymphocytic leukemia (CLL) patients independent of dose. The effect of ibrutinib treatment on basal respiration ( A ), maximal respiration ( B ), spare respiratory capacity ( C ), and respiratory control ratio ( D ) in primary CLL cells from patients pre-treatment and on ibrutinib treatment with low (blue) or standard (grey) dose. N = 14 for low dose and N = 5 for standard dose of ibrutinib. Values are mean ± S.D. **** p < 0.0001 (paired two-tailed Student’s t -test). The reduction of mitochondrial respiration parameters with low and standard dose of ibrutinib treatment is summarized for basal respiration ( E ) and maximal respiration ( F ) in freshly isolated CLL cells. N = 14 for low dose and N = 5 for standard dose of ibrutinib. Values are mean ± S.D. *** p < 0.0005, NS: non-significant (unpaired two-tailed Student’s t -test). In parallel, there is a reduction of chemokine ligands CCL3 ( G ) and CCL4 ( H ) in ibrutinib treated CLL patient plasma samples by dose. Decreased levels of β-2 M and LDH in ibrutinib treated patients compared to pre-treatment ( I , K ) and the decrease of β-2 M or LDH was similar to low or standard dose ibrutinib CLL patients ( J , L ). Demonstration of effects on pBTK, tBTK ( M ), and caspase-3 cleavage ( N ) are independent of dose. OCR: Oxygen consumption rate; resp: Respiratory; IB: Ibrutinib; TX: Treatment; Uncl. caspase-3: Uncleaved caspase-3; Cl. caspase-3: Cleaved caspase-3.

    Journal: Cancers

    Article Title: Ex Vivo Mitochondrial Respiration Parallels Biochemical Response to Ibrutinib in CLL Cells

    doi: 10.3390/cancers13020354

    Figure Lengend Snippet: Ibrutinib has similar effects on mitochondrial respiration profiles, CCL3 and 4, β-2 M, lactate dehydrogenase (LDH), Bruton tyrosine kinase (BTK) signaling and caspase-3 cleavage in chronic lymphocytic leukemia (CLL) patients independent of dose. The effect of ibrutinib treatment on basal respiration ( A ), maximal respiration ( B ), spare respiratory capacity ( C ), and respiratory control ratio ( D ) in primary CLL cells from patients pre-treatment and on ibrutinib treatment with low (blue) or standard (grey) dose. N = 14 for low dose and N = 5 for standard dose of ibrutinib. Values are mean ± S.D. **** p < 0.0001 (paired two-tailed Student’s t -test). The reduction of mitochondrial respiration parameters with low and standard dose of ibrutinib treatment is summarized for basal respiration ( E ) and maximal respiration ( F ) in freshly isolated CLL cells. N = 14 for low dose and N = 5 for standard dose of ibrutinib. Values are mean ± S.D. *** p < 0.0005, NS: non-significant (unpaired two-tailed Student’s t -test). In parallel, there is a reduction of chemokine ligands CCL3 ( G ) and CCL4 ( H ) in ibrutinib treated CLL patient plasma samples by dose. Decreased levels of β-2 M and LDH in ibrutinib treated patients compared to pre-treatment ( I , K ) and the decrease of β-2 M or LDH was similar to low or standard dose ibrutinib CLL patients ( J , L ). Demonstration of effects on pBTK, tBTK ( M ), and caspase-3 cleavage ( N ) are independent of dose. OCR: Oxygen consumption rate; resp: Respiratory; IB: Ibrutinib; TX: Treatment; Uncl. caspase-3: Uncleaved caspase-3; Cl. caspase-3: Cleaved caspase-3.

    Article Snippet: Plasma CCL3 and CCL4 levels were measured pre and post treatment where matched plasma was available (Meso Scale Diagnostics, Rockville, MD [ , ].

    Techniques: Control, Two Tailed Test, Isolation, Clinical Proteomics